This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Is Arch Capital Group (ACGL) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Arch Capital Group (ACGL) and EastGroup Properties (EGP) have performed compared to their sector so far this year.
Here's Why You Should Retain OUTFRONT Media (OUT) Stock Now
by Zacks Equity Research
OUTFRONT Media's (OUT) diversified advertising sites and strategic investments for digital-billboard portfolio bode well. However, competition from its industry peers and high expenses are worrisome.
Boston Properties (BXP) Up 19% in 6 Months: Will the Trend Last?
by Zacks Equity Research
Healthy demand for premier office spaces and life-science asset expansions will likely aid Boston Properties' (BXP) performance. Yet, a choppy office market scenario and high interest rates are woes.
Macerich's (MAC) JV Refinances Tysons Corner, Ups Flexibility
by Zacks Equity Research
Macerich's (MAC) joint venture, which owns Tysons Corner Center, carries out the refinancing of the property for $710 million. The move boosts its financial flexibility and poises it well for growth.
Vornado (VNO) Cuts Dividend by 20%, to Pay One Dividend in 2024
by Zacks Equity Research
Vornado (VNO) cuts its fourth-quarter dividend by 20% to 30 cents per common share, to focus on maintaining its retained cashflows and balance sheet strength. It expects to pay a single dividend in 2024.
SL Green (SLG) to Sell 625 Madison Avenue, Cuts Dividend by 7.7%
by Zacks Equity Research
SL Green (SLG) announces the sale of 625 Madison Avenue for $632.5 million. It also lowers its dividend payout by 7.7% to focus on retaining its cash flows amid a choppy United States office market.
Should Investors Hold Onto Healthpeak (PEAK) Stock for Now?
by Zacks Equity Research
Healthpeak (PEAK) is poised to gain from the robust demand for lab assets and rising senior citizens' healthcare expenditure. However, competition from peers and high interest rates are woes.
Alexandria (ARE) Rises 12% in a Month: Will the Trend Last?
by Zacks Equity Research
Robust demand for top-quality life-science assets in key markets is likely to drive Alexandria's (ARE) performance. However, a vast development outlay exposes it to the risk of rising construction costs.
Vornado (VNO) Surges 61% in 6 Months: Will the Trend Last?
by Zacks Equity Research
Despite a choppy macroeconomic scenario, Vornado's (VNO) ability to offer top-class office assets in key markets is likely to drive its performance. Portfolio-repositioning efforts are encouraging.
Is it Wise to Retain Host Hotels (HST) Stock in Your Portfolio?
by Zacks Equity Research
Strong Sunbelt exposure and capital-recycling efforts are likely to support Host Hotels (HST). However, constrained business transient and group travel demand and high interest rates are concerning.
Diversified Healthcare (DHC) Continues to See Weak SHOP Recovery
by Zacks Equity Research
Despite a rise in Diversified Healthcare's (DHC) SHOP occupancy levels from the pandemic lows, a slower-than-anticipated recovery and rising operating costs continue to keep margins under check.
Pebblebrook (PEB) Witnesses Robust October Operating Trends
by Zacks Equity Research
Pebblebrook (PEB) witnesses strong performance in its urban portfolio, which came in at the higher end of expectations, aiding the operating results for October. However, resort rates moderate.
Welltower's (WELL) Stock Soars 36.7% YTD: Will the Trend Last?
by Zacks Equity Research
A rise in healthcare spending by senior citizens, portfolio restructuring initiatives and balance sheet strength are likely to continue driving Welltower's (WELL) performance in the quarters ahead.
Host Hotels (HST) Gains 12.6% in 3 Months: Will the Trend Last?
by Zacks Equity Research
Recovery in group and business transient travel demand, and capital-recycling moves are likely to aid Host Hotels' (HST) performance in the quarters ahead. Yet, macroeconomic uncertainty is a key woe.
Is it Wise for Investors to Retain Rayonier (RYN) Stock Now?
by Zacks Equity Research
While a solid timberland portfolio, developments in biogenetics and cloning, and capital realignment moves are likely to aid Rayonier (RYN), weak export market demand and high interest rates are woes.
Equinix (EQIX) Stock Up 17% in 6 Months: Will the Trend Last?
by Zacks Equity Research
A globally thriving data-center real estate market is likely to aid Equinix (EQIX) in the quarters ahead. Its recurring revenue model, strategic expansions and robust balance sheet are encouraging.
Iron Mountain's (IRM) Stock Rises 27% YTD: Will the Trend Last?
by Zacks Equity Research
A resilient storage and records management business will likely aid Iron Mountain's (IRM) performance in the quarters ahead. Focus on data-center business expansion is encouraging.
SBA Communications (SBAC) Soars 16.7% QTD: Will the Trend Last?
by Zacks Equity Research
SBA Communications (SBAC) to gain from robust demand for wireless communication assets amid rising mobile data use, expansion efforts and a healthy balance sheet in the near term.
Here's Why You Should Retain Vornado Realty (VNO) Stock Now
by Zacks Equity Research
Vornado Realty (VNO) is well-poised to gain from its top-quality assets. Also, its repositioning efforts bode well. However, choppiness in the office market and a higher interest rate environment are woes.
Should You Retain Cousins Properties (CUZ) Stock for Now?
by Zacks Equity Research
While the healthy demand for premier office spaces, diverse tenant base and capital recycling moves bode well for Cousins Properties (CUZ), a choppy office market and high interest rates are woes.
Key Reasons to Add Iron Mountain (IRM) to Your Portfolio Now
by Zacks Equity Research
Strong cash flows from the storage and records management businesses, data-center business expansion and solid balance sheet are likely to aid Iron Mountain's (IRM) performance in the quarters ahead.
Pebblebrook (PEB) Sells Hotel Zoe Fisherman's Wharf for $68.5M
by Zacks Equity Research
In sync with the company's investment strategy, Pebblebrook (PEB) sells Hotel Zoe Fisherman's Wharf, a 221-room property in San Francisco, CA, for $68.5 million.
Key Reasons to Add Welltower (WELL) to Your Portfolio Now
by Zacks Equity Research
A rise in healthcare spending by senior citizens, strategic portfolio-repositioning efforts and a robust balance sheet are likely to drive Welltower's (WELL) performance in the quarters ahead.
Boston Properties (BXP) to Sell 45% Stake in Two Life-Science Assets
by Zacks Equity Research
Boston Properties (BXP) announces a 45% stake sale in 290 Binney Street and 300 Binney Street in Kendall Square, MA, to Norges Bank Investment Management for a gross valuation of $1.66 billion.
Welltower (WELL) to Dissolve Chartwell JV & Acquire 23 Assets
by Zacks Equity Research
Welltower (WELL) enters into an agreement to dissolve Chartwell JV and acquire the remaining interests in 23 senior housing assets. The move is expected to unlock significant NOI upside, thus making it prudent.